Sally Beauty Holdings (SBH) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Consolidated net sales grew 0.7% year-over-year to $938 million in Q1 FY2025, with comparable sales up 1.6% despite FX headwinds.
Gross profit rose 2.1% to $476.8 million, and operating margin expanded 330 basis points to 10.7%, aided by a $26.6 million gain from the sale of the corporate headquarters.
Net earnings reached $61 million (GAAP), or $0.58 per diluted share; adjusted net earnings were $44.8 million, or $0.43 per share.
Free cash flow enabled investments in growth, debt reduction, and $10 million in share repurchases; $41 million of term loan B debt was repaid.
Cash flow from operations was $33.5 million, and operating free cash flow totaled $57 million, including proceeds from the corporate office sale.
Financial highlights
Gross margin improved 60 basis points to 50.8% year-over-year, driven by lower shrink and supply chain efficiencies.
Adjusted operating margin rose to 8.4%, and adjusted EBITDA margin was 11.7%, up 20 basis points.
Adjusted diluted EPS was $0.43, up 10% year-over-year.
Adjusted SG&A was $398 million, up $5 million, mainly due to higher labor and advertising, partially offset by cost savings.
Net debt leverage ratio improved to 1.9x, with cash and equivalents at $106 million and no borrowings on the revolver.
Outlook and guidance
FY2025 comparable sales expected flat to up 2%, with adjusted operating margin between 8.5% and 9%.
Full-year consolidated net sales now expected to be about 100 basis points below comparable sales due to FX headwinds.
Q2 comparable sales expected to be flat; adjusted operating margin guided at 8%-8.3%.
Management expects existing cash, operations, and available credit to be sufficient for working capital and capital expenditures over the next twelve months.
No material impact anticipated from new international tax regulations (OECD Pillar 2) in fiscal 2025.
Latest events from Sally Beauty Holdings
- Q4 and FY24 saw comp sales growth, margin gains, and a positive outlook for 2025.SBH
Q4 20248 Jul 2026 - Strong Q4 and FY results, margin expansion, and robust cash flow support double-digit EPS growth.SBH
Q4 20258 Jul 2026 - Q2 net sales up 2.3%, margins expanded, cash flow strong, Sally segment led growth.SBH
Q2 202613 May 2026 - Adjusted EPS up 12% as net sales rose 0.6% and FY26 guidance was raised.SBH
Q1 20269 Apr 2026 - Q3 sales up 1.2%, but net earnings fell 25.8% amid margin and interest pressures.SBH
Q3 20242 Feb 2026 - Operating margin and EPS rose despite a 2.8% sales decline and macro headwinds.SBH
Q2 202523 Jan 2026 - Operating margin and EPS rose as guidance was raised, despite lower sales and macro uncertainty.SBH
Q3 202523 Jan 2026 - Virtual annual meeting to vote on directors, compensation, and auditor, with online access promoted.SBH
Proxy Filing10 Dec 2025 - Strong FY25 results, digital expansion, and robust ESG focus drive governance and compensation.SBH
Proxy Filing10 Dec 2025